Compare AMRN & NEWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AMRN | NEWT |
|---|---|---|
| Founded | 1989 | 1998 |
| Country | Ireland | United States |
| Employees | N/A | 572 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 342.8M | 400.6M |
| IPO Year | 1998 | N/A |
| Metric | AMRN | NEWT |
|---|---|---|
| Price | $14.89 | $14.80 |
| Analyst Decision | Strong Sell | Buy |
| Analyst Count | 1 | 3 |
| Target Price | $12.00 | ★ $15.33 |
| AVG Volume (30 Days) | 83.3K | ★ 292.6K |
| Earning Date | 04-29-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 6.00% |
| EPS Growth | ★ 55.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $181,104,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.26 | $12.45 |
| P/E Ratio | ★ N/A | $5.99 |
| Revenue Growth | ★ 39.22 | N/A |
| 52 Week Low | $12.96 | $9.59 |
| 52 Week High | $20.90 | $15.34 |
| Indicator | AMRN | NEWT |
|---|---|---|
| Relative Strength Index (RSI) | 41.75 | 59.33 |
| Support Level | $14.76 | $12.56 |
| Resistance Level | $15.09 | $15.13 |
| Average True Range (ATR) | 0.80 | 0.54 |
| MACD | -0.17 | -0.03 |
| Stochastic Oscillator | 9.43 | 70.06 |
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States.
NewtekOne Inc provides business and financial solutions under the Newtek and NewtekOne brands to the independent business owner (SMB) market. Its services are offered online and in some cases delivered by staff via video and voice calls. The company offers lending products, FDIC insured deposit products and services, payments processing, payroll services and insurance brokerage services. Loan products include SBA 7(a), ALP, SBA 504, and traditional C&I and CRE bank loans, while deposit products include consumer high yield savings accounts, high yield certificates of deposit, zero-fee business checking and business money market accounts. The company operates through four reportable segments Banking, Alternative Lending, NSBF and Payments.